148 related articles for article (PubMed ID: 1608859)
1. Infrequent RAS oncogene mutations in human prostate cancer.
Moul JW; Friedrichs PA; Lance RS; Theune SM; Chang EH
Prostate; 1992; 20(4):327-38. PubMed ID: 1608859
[TBL] [Abstract][Full Text] [Related]
2. Detection of RAS mutations in archival testicular germ cell tumors by polymerase chain reaction and oligonucleotide hybridization.
Moul JW; Theune SM; Chang EH
Genes Chromosomes Cancer; 1992 Sep; 5(2):109-18. PubMed ID: 1381946
[TBL] [Abstract][Full Text] [Related]
3. Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas.
Pergolizzi RG; Kreis W; Rottach C; Susin M; Broome JD
Cancer Invest; 1993; 11(1):25-32. PubMed ID: 7678540
[TBL] [Abstract][Full Text] [Related]
4. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas.
Anwar K; Nakakuki K; Shiraishi T; Naiki H; Yatani R; Inuzuka M
Cancer Res; 1992 Nov; 52(21):5991-6. PubMed ID: 1382850
[TBL] [Abstract][Full Text] [Related]
5. Absent ras gene mutations in human adrenal cortical neoplasms and pheochromocytomas.
Moul JW; Bishoff JT; Theune SM; Chang EH
J Urol; 1993 Jun; 149(6):1389-94. PubMed ID: 8501773
[TBL] [Abstract][Full Text] [Related]
6. Low frequency of H-ras activation in naturally occurring hepatocellular tumors of C3H/HeNCr mice.
Enomoto T; Weghorst CM; Ward JM; Anderson LM; Perantoni AO; Rice JM
Carcinogenesis; 1993 Sep; 14(9):1939-44. PubMed ID: 8403222
[TBL] [Abstract][Full Text] [Related]
7. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
8. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
9. ras gene mutations in human prostate cancer.
Carter BS; Epstein JI; Isaacs WB
Cancer Res; 1990 Nov; 50(21):6830-2. PubMed ID: 2208148
[TBL] [Abstract][Full Text] [Related]
10. [Detection of ras gene mutations of pancreatic tumors by polymerase chain reaction and direct sequencing method].
Tada M; Yokosuka O; Omata M; Ohto M; Isono K
Nihon Shokakibyo Gakkai Zasshi; 1989 Nov; 86(11):2566-71. PubMed ID: 2689731
[TBL] [Abstract][Full Text] [Related]
11. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
[TBL] [Abstract][Full Text] [Related]
12. K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men.
Konishi N; Enomoto T; Buzard G; Ohshima M; Ward JM; Rice JM
Cancer; 1992 May; 69(9):2293-9. PubMed ID: 1562975
[TBL] [Abstract][Full Text] [Related]
13. State of adenomatous polyposis coli gene and ras oncogenes in Japanese prostate cancer.
Suzuki H; Aida S; Akimoto S; Igarashi T; Yatani R; Shimazaki J
Jpn J Cancer Res; 1994 Aug; 85(8):847-52. PubMed ID: 7928631
[TBL] [Abstract][Full Text] [Related]
14. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
15. Mutations of ras genes are relatively frequent in Japanese prostate cancers: pointing to genetic differences between populations.
Shiraishi T; Muneyuki T; Fukutome K; Ito H; Kotake T; Watanabe M; Yatani R
Anticancer Res; 1998; 18(4B):2789-92. PubMed ID: 9713462
[TBL] [Abstract][Full Text] [Related]
16. International comparison on ras gene mutations in latent prostate carcinoma.
Watanabe M; Shiraishi T; Yatani R; Nomura AM; Stemmermann GN
Int J Cancer; 1994 Jul; 58(2):174-8. PubMed ID: 8026877
[TBL] [Abstract][Full Text] [Related]
17. K-ras codon 12 and 61 point mutations in bromodeoxyuridine- and N-nitrosomethylurea-induced rat renal mesenchymal tumors.
Calvert RJ; Buzard GS; Anisimov VN; Rice JM
Cancer Lett; 1996 Dec; 109(1-2):1-7. PubMed ID: 9020896
[TBL] [Abstract][Full Text] [Related]
18. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
19. H-ras oncogene point mutations in arthritic synovium.
Roivainen A; Jalava J; Pirilä L; Yli-Jama T; Tiusanen H; Toivanen P
Arthritis Rheum; 1997 Sep; 40(9):1636-43. PubMed ID: 9324018
[TBL] [Abstract][Full Text] [Related]
20. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]